In rare cases, life-threatening issues such as diverticular hemorrhaging or a perforated colon may occur
The most commonly reported side effects were gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which were generally mild to moderate and most frequent during the dose-escalation phase
In practice, this difference is clinically insignificant for most people
Malabsorption syndromes are not characteristic of GLP-1 therapy
At defined time points (0, 30, 60, and 90 s), 40 L samples were heat inactivated and the aldehyde concentration was determined as detailed above